Financhill
Back

Akebia Therapeutics Quote, Financials, Valuation and Earnings

Akebia Therapeutics Price Quote

$1.84
+0.01 (+2.79%)
(Updated: December 21, 2024 at 5:14 AM ET)

Akebia Therapeutics Key Stats

Sell
39
Akebia Therapeutics (AKBA) is a Sell

Day range:
$1.75 - $1.87
52-week range:
$0.80 - $2.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.20
P/B ratio:
0%

Volume:
5.9M
Avg. volume:
2.2M
1-year change:
52.92%
Market cap:
$400.4M
Revenue:
$194.6M
EPS:
$-0.23

How Much Does Akebia Therapeutics Make?

Data Unavailable

Is Akebia Therapeutics Growing As A Company?

Data Unavailable

Akebia Therapeutics Stock Price Performance

What Is Akebia Therapeutics 52-Week High & Low?

Akebia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akebia Therapeutics?

Data Unavailable

Is Akebia Therapeutics Cash Flow Positive?

Data Unavailable

Akebia Therapeutics Return On Invested Capital

Data Unavailable

Akebia Therapeutics Earnings Date & Stock Price

Akebia Therapeutics Competitors

  • Who Are Akebia Therapeutics's Competitors?
    Below is a list of companies who compete with Akebia Therapeutics or are related in some way:
    • Aldeyra Therapeutics Inc (ALDX)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Akebia Therapeutics Dividend Yield

Data Unavailable

Akebia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -100%
Revenue: -10.98% -15.9%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable